Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.

Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, Biswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM, Everett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston JJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J, Plon SE, Rehm HL, Richards CS, Romasko EJ, Sagardia AM, Spinner NB, Thompson ML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker LG, Hindorff LA.

Genet Med. 2019 May;21(5):1261-1262. doi: 10.1038/s41436-019-0440-2.

PMID:
30670880
2.

Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.

Hart MR, Biesecker BB, Blout CL, Christensen KD, Amendola LM, Bergstrom KL, Biswas S, Bowling KM, Brothers KB, Conlin LK, Cooper GM, Dulik MC, East KM, Everett JN, Finnila CR, Ghazani AA, Gilmore MJ, Goddard KAB, Jarvik GP, Johnston JJ, Kauffman TL, Kelley WV, Krier JB, Lewis KL, McGuire AL, McMullen C, Ou J, Plon SE, Rehm HL, Richards CS, Romasko EJ, Miren Sagardia A, Spinner NB, Thompson ML, Turbitt E, Vassy JL, Wilfond BS, Veenstra DL, Berg JS, Green RC, Biesecker LG, Hindorff LA.

Genet Med. 2019 May;21(5):1100-1110. doi: 10.1038/s41436-018-0308-x. Epub 2018 Oct 5. Erratum in: Genet Med. 2019 Jan 22;:.

PMID:
30287922
3.

Physician Experiences and Understanding of Genomic Sequencing in Oncology.

Weipert CM, Ryan KA, Everett JN, Yashar BM, Chinnaiyan AM, Scott Roberts J, De Vries R, Zikmund-Fisher BJ, Raymond VM.

J Genet Couns. 2018 Feb;27(1):187-196. doi: 10.1007/s10897-017-0134-3. Epub 2017 Aug 24.

4.

Incorporating genetic counseling into clinical care for children and adolescents with cancer.

Everett JN, Mody RJ, Stoffel EM, Chinnaiyan AM.

Future Oncol. 2016 Apr;12(7):883-6. doi: 10.2217/fon-2015-0022. Epub 2016 Feb 18. No abstract available.

5.

Outcomes of genetic evaluation for hereditary cancer syndromes in unaffected individuals.

Gustafson SL, Raymond VM, Marvin ML, Else T, Koeppe E, Stoffel EM, Everett JN.

Fam Cancer. 2015 Mar;14(1):167-74. doi: 10.1007/s10689-014-9756-x.

PMID:
25245322
6.

Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm.

Everett JN, Raymond VM, Dandapani M, Marvin M, Kohlmann W, Chittenden A, Koeppe E, Gustafson SL, Else T, Fullen DR, Johnson TM, Syngal S, Gruber SB, Stoffel EM.

JAMA Dermatol. 2014 Dec;150(12):1315-21.

7.

The clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).

Else T, Marvin ML, Everett JN, Gruber SB, Arts HA, Stoffel EM, Auchus RJ, Raymond VM.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1482-6. doi: 10.1210/jc.2013-3853. Epub 2014 Apr 23.

8.

Traditional roles in a non-traditional setting: genetic counseling in precision oncology.

Everett JN, Gustafson SL, Raymond VM.

J Genet Couns. 2014 Aug;23(4):655-60. doi: 10.1007/s10897-014-9698-3. Epub 2014 Mar 1.

9.

An oncocytic adrenal tumour in a patient with Birt-Hogg-Dubé syndrome.

Raymond VM, Long JM, Everett JN, Caoili EM, Gruber SB, Stoffel EM, Giordano TJ, Hammer GD, Else T.

Clin Endocrinol (Oxf). 2014 Jun;80(6):925-7. doi: 10.1111/cen.12292. Epub 2013 Aug 5. No abstract available.

10.

Adrenocortical carcinoma is a lynch syndrome-associated cancer.

Raymond VM, Everett JN, Furtado LV, Gustafson SL, Jungbluth CR, Gruber SB, Hammer GD, Stoffel EM, Greenson JK, Giordano TJ, Else T.

J Clin Oncol. 2013 Aug 20;31(24):3012-8. doi: 10.1200/JCO.2012.48.0988. Epub 2013 Jul 22. Erratum in: J Clin Oncol. 2013 Oct 1;31(28):3612.

11.

Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma.

Raymond VM, Else T, Everett JN, Long JM, Gruber SB, Hammer GD.

J Clin Endocrinol Metab. 2013 Jan;98(1):E119-25. doi: 10.1210/jc.2012-2198. Epub 2012 Nov 21.

12.

Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.

Christensen KD, Roberts JS, Shalowitz DI, Everett JN, Kim SY, Raskin L, Gruber SB.

Cancer Epidemiol Biomarkers Prev. 2011 Mar;20(3):522-9. doi: 10.1158/1055-9965.EPI-10-1045. Epub 2011 Feb 9.

13.

Returning individual research results: development of a cancer genetics education and risk communication protocol.

Roberts JS, Shalowitz DI, Christensen KD, Everett JN, Kim SY, Raskin L, Gruber SB.

J Empir Res Hum Res Ethics. 2010 Sep;5(3):17-30. doi: 10.1525/jer.2010.5.3.17.

14.

Genetic counselling and genetic testing in hereditary gastrointestinal cancer syndromes.

Raymond VM, Everett JN.

Best Pract Res Clin Gastroenterol. 2009;23(2):275-83. doi: 10.1016/j.bpg.2009.02.009. Review.

PMID:
19414152
15.

Differences in physician referral practices and attitudes regarding hereditary breast cancer by clinical practice location.

Koil CE, Everett JN, Hoechstetter L, Ricer RE, Huelsman KM.

Genet Med. 2003 Sep-Oct;5(5):364-9.

PMID:
14501831
16.

Breast cancer genetics education for college women: an evaluation of approaches.

Howell KA, Huelsman KM, Everett JN, Hopkin RJ.

J Cancer Educ. 2002 Summer;17(2):74-7.

PMID:
12092856

Supplemental Content

Loading ...
Support Center